SEC Form 4 · accession 0001479791-18-000012
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claude Ranoux
10% Owner
Period of report
Feb 6, 2018
Accepted (ET)
Feb 8, 2018 · 3:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO Bioscience Common Stock | Feb 6, 2018 | S | 100 | $0.112 | D | 25,463,899 | D | |
| INVO Bioscience Common Stock | Feb 7, 2018 | S | 16,015 | $0.1115 | D | 25,447,884 | D |
Table II — derivative securities
No Table II lines on this filing.